Director/PDMR Shareholding
Oxford Biomedica plc announced that Kathleen Miller, Head of Human Resources, exercised 4,486 Restricted Share Units under the 2024 LTIP Plan at a nil exercise price on May 18, 2026. Subsequently, Ms. Miller disposed of 1,578 ordinary shares at an average price of £6.091 per share on the same date, generating a total of £9,611.60 from this sale.
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Oxford, UK - 19 May 2026: OXB (LSE: OXB) (the "Company"), a global quality and innovation-led cell and gene therapy CDMO, today announces that Kathleen Miller has exercised 4,486 Restricted Share Units ("RSU") options granted under the 2024 Long Term Incentive Plan ("2024 LTIP Plan") at an exercise price of £nil on 18 May 2026 and disposed of 1,578 ordinary shares at an average price of £6.091 per share on 18 May 2026.
The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further details of the transaction.
| 1. | Details of the p erson discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | |||||
| a) | Is this a PDMR or PCA submission | Submission for PDMR | ||||
| b) | Name of natural person | Kathleen Miller | ||||
| c) | Legal person | |||||
| 2. | Reason for the notification | |||||
| a) | Position/status | Head of Human Resources (and acting Interim Site Head, Bedford Operations) | ||||
| b) | Initial notification/ amendment | Initial Notification | ||||
| 3. | Details of the Issuer | |||||
| a) | Full name of the entity | Oxford Biomedica plc | ||||
| b) | LEI code | 213800S1GVQNXQ15K851 | ||||
| a) | Date of the transaction | 18-May-2026 | ||||
| b) | Description of the financial instrument | Share | ||||
| c) | Identification code | ISIN: GB00BDFBVT43 | ||||
| d) | Nature of the transaction | Exercise of 4,486 RSUs under 2024 LTIP Plan | ||||
| e) | Place of the transaction | Outside the trading venue | ||||
| f) | Currency | GBP - British pound | ||||
| g) | Price(s) and volumes(s) |
| ||||
| h) | Aggregated information - Aggregate volume - Price - Aggregated total | 4,486 £0.00 £0.00 | ||||
| 1. | Details of the p erson discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | |||||
| a) | Is this a PDMR or PCA submission | Submission for PDMR | ||||
| b) | Name of natural person | Kathleen Miller | ||||
| c) | Legal person | |||||
| 2. | Reason for the notification | |||||
| a) | Position/status | Head of Human Resources (and acting Interim Site Head, Bedford Operations) | ||||
| b) | Initial notification/ amendment | Initial Notification | ||||
| 3. | Details of the Issuer | |||||
| a) | Full name of the entity | Oxford Biomedica plc | ||||
| b) | LEI code | 213800S1GVQNXQ15K851 | ||||
| a) | Date of the transaction | 18-May-2026 | ||||
| b) | Description of the financial instrument | Share | ||||
| c) | Identification code | ISIN: GB00BDFBVT43 | ||||
| d) | Nature of the transaction | Sale of 1,578 ordinary shares | ||||
| e) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||
| f) | Currency | GBP - British pound | ||||
| g) | Price(s) and volumes(s) |
| ||||
| h) | Aggregated information - Aggregate volume - Price - Aggregated total | 1,578 £6.091 £9,611.60 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.